ebrotidine has been researched along with Necrosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrade, RJ; Bellot, V; Bermudez, F; Cárdenas, F; Fernandez, MC; Garcia-Escaño, MD; Gomez-Outes, A; Hervás, A; Lucena, MI; Martin-Vivaldi, R; Nogueras, F; Pelaez, G; Romero, M; Salmerón, J | 1 |
1 other study(ies) available for ebrotidine and Necrosis
| Article | Year |
|---|---|
Acute liver injury associated with the use of ebrotidine, a new H2-receptor antagonist.
Topics: Acute Disease; Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Benzenesulfonates; Bilirubin; Chemical and Drug Induced Liver Injury; Female; Histamine H2 Antagonists; Humans; Liver; Liver Failure; Male; Middle Aged; Necrosis; Thiazoles | 1999 |